Roundtable Discussion; The Future of Mineral Sands. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksQFI.L Regulatory News (QFI)

  • There is currently no data for QFI

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Extension of Contracts with AkzoNobel

14 Sep 2016 07:00

RNS Number : 7467J
Quadrise Fuels International PLC
14 September 2016
 

14 September 2016

 

Quadrise Fuels International Plc

("QFI", "Quadrise" or the "Company")

Extension of contracts with AkzoNobel,

 providing on-going support for global MSAR® projects

 

Quadrise Fuels International plc (AIM: QFI) is the emerging supplier of MSAR® emulsion technology and fuel, enabling a low cost alternative to heavy fuel oil (one of the world's largest fuel markets, comprising over 450 million tons per annum) for the global shipping, refining and power generation industries.

 

The Company is pleased to announce it has extended two contracts with AkzoNobel group companies ("AkzoNobel") for the exclusive purchase and supply of goods and services, and for the continued exclusive joint development of emulsion fuels.

 

These contracts, originally signed in November 2013, replaced the original Alliance Agreement between Quadrise and AkzoNobel that was entered into in 2004. The contract extensions ensure continuity and on-going support from AkzoNobel for the commercialisation of MSAR® projects globally, and will now run until at least November 2018.

 

Commenting on this development:

 

Mike Kirk, Executive Chairman of QFI, said:

 

"The extension of these agreements with our core technology partner, AkzoNobel, reinforce the commitment of both parties to commercialising the global MSAR® business. Our long-term relationship with AkzoNobel continues to underpin our ability to move the Company towards long-term commercial revenues as our major projects evolve."

 

Staffan Asplund, R&D Director of AkzoNobel Surface Chemistry, said:

 

"We are excited about the recent developments around the MSAR® technology and pleased about the extended agreements between AkzoNobel and QFI. This solidifies a long-standing partnership that has led to remarkable technical progress. It is also a great example of how a unique and customized surfactant system is the essential ingredient behind a revolutionary fuel technology that will benefit several industries in the near future."

 

Background to the AkzoNobel Agreements:

 

Quadrise International Limited (QIL), the 100% owned operating subsidiary of QFI, is the contracting party for both agreements originally signed in November 2013.

 

Co-operation and Exclusive Purchase and Supply Agreement

 

This agreement between QIL and AkzoNobel Surface Chemistry AB ("ANSC") defines the commercial relationship relating to the purchase and supply of goods and associated technical services to projects in development. QIL acquire or facilitate the supply of MSAR® Manufacturing Units directly from suppliers for sale to refiners. For fuel applications QIL buy goods such as emulsifiers exclusively from ANSC, which ANSC supply exclusively to QIL. QIL supply goods and services directly to refiners licensed by QIL to use Quadrise MSAR® Technology. The agreement term has been extended for a further two years, expiring on 12 November 2018 unless extended by the parties.

 

Joint Development Agreement

 

This agreement between QIL and AkzoNobel Chemicals BV deals with joint technical programmes that support new business opportunities and are principally focussed on the formulation and processing of novel fuel emulsions to optimise performance and cost.

Intellectual Property arising from these programmes (including past work such as MSAR® Marine fuels development) is jointly owned. The agreement is exclusive in the field of emulsion fuels research and development. The agreement extension provides joint support for a number of specified projects now up to 10 November 2018. The overriding term of the agreement is, however, evergreen, subject to 12 months' notice for termination by either party.

 

 

This announcement is inside information for the purposes of Article 7 of Regulation 596/2014.

 

 

For further information, please refer to the Company's website at www.quadrisefuels.com or contact:

  

 

Quadrise Fuels International plc

Mike Kirk, Executive Chairman

+44 (0)20 7031 7321

Hemant Thanawala, Finance Director

Jason Miles, Chief Operating Officer

 

Nominated Adviser

Smith & Williamson Corporate Finance Ltd

Dr Azhic Basirov

+44 (0)20 7131 4000

Ben Jeynes

 

Broker

Peel Hunt LLP

Richard Crichton

+44 (0)20 7418 8900

Ross Allister

 

Public & Investor Relations

FTI Consulting

Ben Brewerton

Sara Powell

+44 (0)20 3727 1000

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
CNTZMGMLVFZGVZM
Date   Source Headline
2nd Feb 20217:00 amRNSUpdate re Morocco and Greenfield Energy Projects
1st Feb 20217:00 amRNSUpdate re bioMSAR Testing at Aquafuel Research Ltd
27th Jan 20217:00 amRNSIssue of Equity
21st Jan 20217:00 amRNSJoint Development Agreement - MSC Shipmanagement
6th Jan 20217:00 amRNSIssue of Equity
4th Jan 20217:00 amRNSChange of Registered Office
18th Dec 202011:46 amRNSUpdate re Greenfield MSAR Trial
18th Dec 20207:00 amRNSbioMSAR Testing Update & Collaboration Agreement
15th Dec 20207:00 amRNSLaunch of bioMSAR
3rd Dec 20207:00 amRNSPublication of Americas White Paper
27th Nov 202012:13 pmRNSResult of AGM
27th Nov 20207:00 amRNSAGM Statement
24th Nov 20208:00 amEQSQuadrise Fuels International (QFI): The clean solution to a global problem
2nd Nov 20205:23 pmRNSPosting of Annual Report and Notice of AGM
26th Oct 20207:00 amRNSMorocco Update
5th Oct 20207:00 amRNSFinal Results, Investor Presentation & AGM Notice
7th Sep 20205:56 pmRNSIssue of Equity
7th Sep 20207:00 amRNSNotice of Results, Update and Investor Event
24th Aug 20207:00 amRNSIssue of Share Options
20th Aug 20207:00 amRNSIssue of Equity
18th Aug 20207:22 amRNSGreenfield MSAR Commercial Trial Agreement
17th Aug 20207:00 amRNSPublication of White Paper
17th Jul 20203:59 pmRNSInvestor Presentation
30th Jun 20209:18 amRNSHolding(s) in Company
24th Jun 20204:41 pmRNSSecond Price Monitoring Extn
24th Jun 20204:37 pmRNSPrice Monitoring Extension
23rd Jun 20207:00 amRNSIssue of Equity
18th Jun 20207:00 amRNSStatement re MSAR Licensing and Upstream Trial
17th Jun 20201:47 pmRNSStatement re MSAR Licensing
2nd Jun 20207:00 amRNSInvestor Presentation
1st May 20207:00 amRNSFurther Statement re Covid-19 and Update
16th Apr 20202:21 pmRNSIssue of Equity
15th Apr 20207:00 amRNSDirectorate Change
30th Mar 20204:13 pmRNSNew Website
30th Mar 202011:02 amRNSHalf-year Report - Replacement
30th Mar 20207:00 amRNSHalf-year Report
24th Mar 202010:13 amRNSIssue of Equity
16th Mar 20207:00 amRNSStatement re Covid-19 and Morocco Pilot Trial
5th Mar 20209:10 amRNSUpdate on Morocco Pilot Trial
17th Feb 20207:00 amRNSNotice of Interim Results and Business Update
30th Jan 20207:00 amRNSAppointment of New Auditors
15th Jan 20207:00 amRNSDirectorate Changes
16th Dec 20198:38 amRNSDirectorate Change
29th Nov 20194:42 pmRNSResult of AGM
29th Nov 20197:05 amRNSIssue of Warrants
29th Nov 20197:00 amRNSAGM Update
29th Nov 20197:00 amRNSMaterial Transfer & Cooperation Agreement
6th Nov 20195:03 pmRNSPosting of Annual Report and Notice of AGM
10th Oct 20195:42 pmRNSHolding(s) in Company
8th Oct 20197:00 amRNSNew three-year Exclusive Agreement with Nouryon

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.